Retlirafusp Alfa Plus Chemotherapy as Neoadjuvant Therapy for Thoracic ESCC
Clinical trial NCT07618910 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07618910
- Sponsor
- Tang-Du Hospital
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-05-30
- Primary completion
- 2027-05-30
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.